Drug class
Bisphosphonate ligand; diagnostic radiopharmaceutical precursor for technetium-99m bone imaging
Mechanism of action
Oxidronate (hydroxymethylene diphosphonate, HMDP/HDP) chelates technetium-99m in radiopharmaceutical kits. The labelled complex localises to hydroxyapatite at sites of increased osteoblastic activity, permitting skeletal scintigraphy.
General use cases
- Used as the active ligand in technetium-99m oxidronate (HDP/HMDP) for skeletal scintigraphy and assessment of areas of increased bone turnover. Diagnostic imaging uses the technetium-labelled formulation.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
